The last two decades have seen the introduction of several therapies for multiple sclerosis (MS). These...
ادامه مطلبDimethyl fumarate (BG-12, Tecfidera®) is a new oral drug approved by FDA and EMA in March 2013 for relapsing...
ادامه مطلبThe current Multiple Sclerosis (MS) therapeutic landscape is rapidly growing.
ادامه مطلبTo evaluate the safety, tolerability, and efficacy of glatiramer acetate (GA) 40 mg daily vs the approved...
ادامه مطلبMultiple sclerosis (MS) is a disease that mainly affects young adults who are of reproductive age. MS...
ادامه مطلبPatients with multiple sclerosis (MS) demonstrate thinning of peripapillary retinal nerve fiber layer...
ادامه مطلبMultiple sclerosis (MS) is a common inflammatory demyelinating disorder of the central nervous system....
ادامه مطلبTo evaluate the safety, tolerability, and efficacy of glatiramer acetate (GA) 40mg compared to a 20mg...
ادامه مطلبTo assess the efficacy and safety of glatiramer acetate (GA) 40mg administered 33 weekly (tiw) compared...
ادامه مطلبMitoxantrone has been approved by the FDA for worsening relapsing remitting and secondary progressive...
ادامه مطلبOral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
ادامه مطلب